$ANIX

Anixa Biosciences Inc

Nasdaq · Healthcare · Pharmaceutical Preparations · San Jose, CA

ANIX chart

What traders are saying about $ANIX

Latest posts

Anixa Biosciences Inc news

Anixa Biosciences Inc key financials

USD2025202420232022
Revenue–$210,000$210,000–
Net income-$10.9M-$12.6M-$9.8M-$13.6M
Diluted EPS$-0.34$-0.39$-0.32$0.45
Total assets (year end)$15.2M$18.9M$25.4M$28.3M
Cash and equivalents (year end)$1.5M$1.1M$998,000$9.8M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Anixa Biosciences Inc

Ticker
ANIX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Jose, CA
Incorporated in
DE
Fiscal year end
October 31
SEC CIK
715446
Former names
ITUS Corp, COPYTELE INC

Frequently asked questions

What exchange is Anixa Biosciences Inc listed on?

Anixa Biosciences Inc trades on the Nasdaq under the ticker symbol ANIX.

What industry is Anixa Biosciences Inc in?

Anixa Biosciences Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Anixa Biosciences Inc headquartered?

Anixa Biosciences Inc's business address on file with the SEC is in San Jose, CA.

When does Anixa Biosciences Inc's fiscal year end?

Anixa Biosciences Inc's fiscal year ends on October 31.

How much revenue did Anixa Biosciences Inc report?

Anixa Biosciences Inc reported $210,000 in revenue for calendar year 2024, according to its SEC filings.